NVP Associates, LLC
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 15, 2026), NVP Associates, LLC reported 5 stock positions worth $176.2 million. Its top holding was MBX Biosciences (MBX) at 36.2% of the portfolio, followed by Billiontoone Class A (BLLN, 23.0%) and Zenas Biopharma (ZBIO, 20.4%). Compared with Q4 2025, it sold out of 1. The biggest sale was an exit from Talkspace (TALK).
- Most Recent 13F
- Q2 2026
- Location
- MENLO PARK, CA
- CIK
- 0001545692
- Portfolio Value
- $176.2M (Q1 2026)
- SEC Filing
- 0001545692-26-000005 ↗ filed May 15, 2026
Holdings Value
Holdings 5 stocks · $176.2M
| MBX MBX Biosciences Inc. | 36.20% | 2,136,335 | $63.8M | No change |
| BLLN Billiontoone Inc. Class A | 23.00% | 513,330 | $40.5M | No change |
| ZBIO Zenas Biopharma Inc. | 20.40% | 1,838,482 | $35.9M | No change |
| OMDA Omada Health Inc. | 18.06% | 2,531,000 | $31.8M | No change |
| GROV Grove Collaborative Holdings | 2.34% | 3,225,097 | $4.1M | No change |
Portfolio Sells Q4 2025 → Q1 2026
| TALK Talkspace Inc. | Sold out | 0.00% | −13.94 |
Portfolio Buys Q4 2025 → Q1 2026
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 7 | $328.2M | MBX, AVLN, OMDA, ZBIO, SNOW |
| Q1 2026 | 5 | $176.2M | MBX, BLLN, ZBIO, OMDA, GROV |
| Q4 2025 | 6 | $255.2M | MBX, ZBIO, BLLN, OMDA, TALK |
| Q3 2025 | 5 | $166.1M | OMDA, ZBIO, MBX, TALK, GROV |
| Q2 2025 | 7 | $184.2M | DAVE, OMDA, TALK, MBX, ZBIO |
| Q1 2025 | 6 | $112.2M | DAVE, TALK, MBX, ZBIO, GROV |
| Q4 2024 | 7 | $186.9M | DAVE, TALK, MBX, UDMY, ZBIO |
| Q3 2024 | 8 | $176.1M | MBX, ZBIO, TALK, DAVE, UDMY |
| Q2 2024 | 6 | $91.3M | TALK, UDMY, DAVE, OPEN, GROV |
| Q1 2024 | 6 | $125.9M | TALK, UDMY, DAVE, OPEN, GROV |